Search - tctmd.com

Displaying 21 - 40 of 333

Sort: Relevancy | Date

News Daily News

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

Caitlin E. Cox

December 04, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

Healthy Behaviors Linked to Lower Risk of Subclinical Atherosclerosis in Middle-aged Women

Yael L. Maxwell

November 30, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

NICE Revisits UK Stroke Guidance, Including Thrombectomy

Caitlin E. Cox

November 30, 2018

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

Top Stories in Cardiology: November 2018

Podcast Heart Sounds

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Daily News

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Shelley Wood

November 23, 2018

News Daily News

Bullying or Violence on the Job May Boost CVD Risk

Todd Neale

November 22, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Conference News AHA 2018

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

Todd Neale

November 19, 2018

News Daily News

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

Todd Neale

November 19, 2018

News Conference News AHA 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Yael L. Maxwell

November 16, 2018

News Conference News AHA 2018

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

Yael L. Maxwell

November 16, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

Advertisement

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Healthy Behaviors Linked to Lower Risk of Subclinical Atherosclerosis in Middle-aged Women

TCTMD’s Top 10 Most Popular Stories for November 2018

NICE Revisits UK Stroke Guidance, Including Thrombectomy

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Top Stories in Cardiology: November 2018

Aspirin Should Play Limited Role in Primary Prevention: Review

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Bullying or Violence on the Job May Boost CVD Risk

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Concerning Decline in Antibiotic Prophylaxis for Infective Endocarditis

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content